Effects of light on metalloporphyrin-treated newborn mice

Acta Paediatr. 2014 May;103(5):474-9. doi: 10.1111/apa.12554. Epub 2014 Jan 31.

Abstract

Zinc protoporphyrin (ZnPP) is a promising metalloporphyrin with sufficient potency, but has poor solubility and is not absorbed well orally. Intragastric administration of ZnPP microparticles (30 μmol/kg) to 3-day-old mice resulted in a twofold increase in potency and no signs of phototoxicity.

Conclusion: The use of polymeric particulate delivery systems can improve the stability and enhance intestinal absorption of ZnPP, while retaining HO inhibitory potency without photosensitising effects, and thus is potentially useful in treating neonatal hyperbilirubinemia.

Keywords: Bilirubin; Heme oxygenase; Metalloporphyrin; Neonatal jaundice; Phototoxicity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems
  • Enzyme Inhibitors / therapeutic use*
  • Heme Oxygenase (Decyclizing) / antagonists & inhibitors
  • Hyperbilirubinemia, Neonatal / drug therapy*
  • Hyperbilirubinemia, Neonatal / prevention & control
  • Light / adverse effects*
  • Metalloporphyrins / therapeutic use*
  • Mice
  • Photosensitizing Agents / therapeutic use*
  • Protoporphyrins / therapeutic use*

Substances

  • Enzyme Inhibitors
  • Metalloporphyrins
  • Photosensitizing Agents
  • Protoporphyrins
  • zinc protoporphyrin
  • Heme Oxygenase (Decyclizing)